Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.935
+0.075 (3.99%)
Nov 5, 2024, 1:22 PM EST - Market open

Immuneering Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-56.07-53.47-50.51-33.54-17.04-7.71
Depreciation & Amortization
0.380.350.80.160.080.02
Loss (Gain) From Sale of Assets
000.01---
Loss (Gain) From Sale of Investments
-0.88-1.02-0.170.13--
Stock-Based Compensation
6.265.734.061.81.090.6
Other Operating Activities
0.370.41--0.31-2.22
Change in Accounts Receivable
-0.010.230.28-0.290.61
Change in Accounts Payable
-0.1-1.111.76-0.131.190.27
Change in Unearned Revenue
------0.47
Change in Other Net Operating Assets
-0.770.12-0.280.750.360.02
Operating Cash Flow
-50.82-48.97-44.1-30.85-14.62-4.44
Capital Expenditures
-0.3-0.34-0.74-0.06-0.05-0.02
Cash Acquisitions
---0.07--
Investment in Securities
5.827.6442.57-75.63--
Investing Cash Flow
5.527.341.83-75.62-0.05-0.02
Short-Term Debt Issued
-----3.83
Total Debt Issued
-----3.83
Net Debt Issued (Repaid)
-----3.83
Issuance of Common Stock
1.0128.640.3121.6--
Other Financing Activities
--0.2-0.28-2.12--0.06
Financing Cash Flow
1.0128.440.02144.2637.9817.17
Net Cash Flow
-44.29-13.23-2.2537.823.3112.71
Free Cash Flow
-51.12-49.31-44.84-30.91-14.67-4.46
Free Cash Flow Margin
---14148.44%-1486.17%-634.83%-232.48%
Free Cash Flow Per Share
-1.74-1.74-1.70-2.27-2.96-0.90
Levered Free Cash Flow
-31.61-31.1-25.99-18.59-8.25-
Unlevered Free Cash Flow
-31.61-31.1-25.99-18.59-8.25-
Change in Net Working Capital
0.110.33-2.23-0.69-1.31-
Source: S&P Capital IQ. Standard template. Financial Sources.